918
I. Hachiya et al. / Tetrahedron: Asymmetry 18 (2007) 915–918
Nakamura, K.; Hirose, Y. J. Synth. Org. Chem. Jpn. 1995,
53, 668–677.
7. 2-Benzyloxypropane-1,3-diol 3c was prepared according to
the literature method Nali, M.; Rindone, B. Gazz. Chim. Ital.
1986, 116, 25–27.
3. The diastereomeric excess of 1-momoricinolein 2a was
determined by the HPLC analysis of its tribenzoate ester.
4. 2-Benzyloxymethoxypropane-1,3-diol (3a) and 2-methoxy-
methoxypropane-1,3-diol (3b) were prepared according to the
literature method and its modification, respectively. Chong, J.
M.; Sokoll, K. K. Tetrahedron Lett. 1992, 33, 879–882.
5. Hachiya, I.; Makino, A.; Shimizu, M.; Akita, M.; Hama-
guchi, T. Tetrahedron: Asymmetry 2004, 15, 2451–2454.
6. General procedure for the synthesis of 1-monoicinolein deriv-
atives 2. To a solution of 1,3-diricinolein derivative 1c
(1186.2 mg, 1.70 mol) in THF (8.0 mL) and phosphate buffer
(24.0 mL) was added lipase PS (101.6 mg) at room temper-
ature under an air. The mixture was stirred at room
temperature for 25 min and then filtered through a Celite
pad, which was washed with EtOAc. The filtrate was washed
with brine and dried over Na2SO4. The solvents were
evaporated in vacuo, and then the residue was purified by
silica gel column chromatography (hexane/EtOAc = 4/1) to
give 1-monoricinolein derivative 2c (224.4 mg, 32%, 51%
based on the recovered 1c) as a colorless oil and a mixture of
the recovered 1c and ricinoleic acid (942.2 mg, 48%, 39%,
respectively, by 1H NMR analysis). 1H NMR (500 MHz,
CDCl3): d 0.88 (t, J = 7.0 Hz, 3H), 1.24–1.40 (m, 16H), 1.40–
1.53 (m, 2H), 1.55–1.72 (m, 3H), 2.00–2.09 (m, 2H), 2.18–2.24
(m, 2H), 2.30–2.37 (m, 2H), 2.70 (s, 1H), 3.43 (s, 3H), 3.56–
3.73 (m, 3H), 3.78–3.88 (m, 1H), 4.17 (dd, J = 5.2, 11.6 Hz,
1H), 4.21 (dd, J = 5.6, 11.6 Hz, 1H), 4.74 (s, 2H), 5.35–5.46
(m, 1H), 5.52–5.60 (m, 1H). 13C NMR (67.8 MHz, CDCl3): d
13.9, 14.0, 22.5, 24.7, 25.6, 27.2, 28.9, 29.0, 29.2, 29.4, 31.7,
34.0, 35.2, 36.7, 55.5, 62.3, 63.2, 71.4, 76.5, 96.4, 125.2, 132.9,
173.6. IR (neat): 3418, 2927, 2855, 1737, 1459, 1156, 1113,
8. Waldinger, C.; Schneider, M. J. Am. Oil. Chem. Soc. 1996,
73, 1513–1519.
9. General procedure for the synthesis of (2R)-1-monoicinolein
derivatives 2 using lipase-catalyzed transesterification of the
2-protected glycerol 3 with vinyl ricinoleate 5. To vinyl
ricinoleate 5 (32.5 mg, 0.100 mol) was added a solution of
2-benzyloxypropane-1,3-diol (3c) in MeCN (1.5 mL) at room
temperature under an argon atmosphere and the mixture was
stirred at 50 °C for 5 min. Lipase AK (20.0 mg) was added to
the resulting mixture at 50 °C. The mixture was stirred at
50 °C for 12.0 h and then filtered through a Celite pad, which
was washed with EtOAc. The filtrate was washed with brine
and dried over Na2SO4. The solvents were evaporated in
vacuo, and then the residue was purified by silica gel column
chromatography (hexane/EtOAc = 1/2) to give 2d (29.7 mg,
1
64%) as a colorless oil. H NMR (500 MHz, CDCl3): d 0.88
(t, J = 6.7 Hz, 3H), 1.23–1.38 (m, 16H), 1.41–1.47 (m, 3H),
1.59–1.64 (m, 3H), 2.04 (t, J = 7.0 Hz, 2H), 2.20 (t,
J = 7.3 Hz, 2H), 2.32 (t, J = 7.3 Hz, 2H), 3.57–3.66 (m,
2H), 3.68–3.74 (m, 2H), 4.23–4.24 (m, 2H), 4.60 (d,
J = 11.6 Hz, 1H), 4.72 (d, J = 11.6 Hz, 1H), 5.37–5.42 (m,
1H), 5.52–5.58 (m, 1H), 7.30–7.36 (m, 5H). 13C NMR
(67.8 MHz, CDCl3): d 173.8, 137.8, 133.3, 128.5, 128.0,
127.8, 125.2, 77.2, 72.1, 71.5, 62.6, 62.0, 36.8, 35.3, 34.2, 31.8,
29.5, 29.3, 29.1, 29.0, 29.0, 27.3, 25.7, 24.9, 22.6, 14.1. 14.1,
22.6, 24.9, 25.7, 27.3, 29.0, 29.0, 29.1, 29.3, 29.5, 31.8, 34.2,
35.3, 36.8, 62.0, 62.6, 71.5, 72.1, 77.2, 125.2, 127.8, 128.0,
128.5, 133.3, 137.8, 173.8. IR (neat): 3418, 2927, 2857, 1736,
24
1457, 1178, 1117, 1060, 737, 699 cmꢀ1. ½aꢁD ¼ ꢀ8:5 (c 0.218,
CHCl3).
21
1034, 919, 725 cmꢀ1. ½aꢁD ¼ þ8:2 (c 0.093, CHCl3).
10. Kato, Y.; Fujiwara, I.; Asano, Y. J. Mol. Catal. B: Enzym.
2000, 9, 193–200.
The diastereomeric excesses of 1-momoricinolein derivatives
2b and 2c were determined by HPLC analysis of their
dibenzoates 7b and 7c. To a solution of 1-monoricinolein
derivative 2c (2.7 mg, 0.0065 mmol) in CH2Cl2 (1.5 mL) was
added pyridine (0.020 mL, 0.25 mmol) at 0 °C under an argon
atmosphere and the mixture was stirred at 0 °C for 5 min.
Benzoyl chloride (0.040 mL, 0.34 mmol) was added to the
resulting mixture at 0 °C. The mixture was warmed to room
temperature and then stirred for 14.0 h. HCl (2 M) was added
to quench the reaction. The mixture was extracted with
EtOAc. The combined extracts were washed with H2O,
saturated aqueous NaHCO3, and brine and dried over
Na2SO4. The solvents were evaporated in vacuo, and then
the residue was purified on preparative TLC (hexane/
EtOAc = 9/1) to give 7c along with a small amount of
impurities. Further purification on preparative TLC (hexane/
EtOAc = 1/1) gave pure 7c (10.9 mg, 99%) as a colorless oil.
The de of 7c was determined as 94% by HPLC analysis
(DAICEL CHIRALCEL OD, hexane/2-propanol = 50/1 (v/
v)), at a flow rate of 0.3 mL minꢀ1. The minor (2R)-7c was
eluted first (t2R = 32.5 min), followed by major (2S)-7c
(t2S = 37.0 min).1H NMR (270 MHz, CDCl3): d = 0.86 (t,
J = 6.6 Hz, 3H), 1.26–1.38 (m, 16H), 1.59–1.70 (m, 4H), 2.01–
2.05 (m, 2H), 2.33 (t, J = 7.6 Hz, 2H), 2.43 (dd, J = 5.9,
11.6 Hz, 2H), 3.39 (s, 3H), 4.15–4.51 (m, 5H), 4.76 (s, 2H),
5.11–5.16 (m, 1H), 5.38–5.47 (m, 2H), 7.40–7.47 (m, 4H),
7.52–7.57 (m, 2H), 8.00–8.06 (m, 4H). 13C NMR (67.8 MHz,
CDCl3): d = 14.0, 22.5, 24.8, 25.4, 27.3, 29.0, 29.1, 29.2, 29.5,
31.7, 32.0, 33.7, 34.1, 55.6, 63.4, 64.0, 72.7, 74.6, 77.2, 96.0,
124.1, 128.2, 128.4, 129.5, 129.6, 129.7, 130.7, 132.7, 133.2,
166.2, 173.5. IR (neat): 2928, 2856, 1721, 1602, 1453, 1273,
11. Configurations of product 2a and 2c were tentatively assigned
by analogy.
12. Procedure for the synthesis of 1,3-diacyl glycerol derivative 9.
To
55.5 mg,
a
mixture of 1-monoricinolein (2S)-2c (94.2% de,
0.133 mmol) and 4-dimethylaminopyridine
(DMAP) (37.4 mg, 0.306 mmol) was added a solution of
4-(4-hexyloxyphenyl)-benzoic acid (59.6 mg, 0.200 mmol) in
CH2Cl2 (2.0 mL) at room temperature under an argon
atmosphere and the mixture was stirred at 0 °C for 5 min. A
solution of N,N0-dicyclohexylcarbodiimide (DCC) (68.7 mg,
0.333 mmol) in CH2Cl2 (2.0 mL) was added to the resulting
mixture at 0 °C. The mixture was allowed to warm to room
temperature and then stirred for 48 h. The mixture was
filtered through a Celite pad, which was washed with
EtOAc. The filtrate was washed with 0.5 M HCl and dried
over Na2SO4. The solvents were evaporated in vacuo, and
then the residue was purified on preparative TLC (hexane/
EtOAc = 6/1) to give 1,3-diacyl glycerol derivative
9
(30.5 mg, 33%) as a colorless oil. 1H NMR (270 MHz,
CDCl3): d 0.80–0.90 (m, 6H), 1.20–1.40 (m, 20H), 1.40–1.53
(m, 4H), 1.52–1.72 (m, 3H), 1.76–1.86 (m, 2H), 1.98–2.12
(m, 2H), 2.18–2.23 (m, 2H), 2.35 (t, J = 7.4 Hz, 2H), 3.41 (s,
3H), 3.55–3.68 (m, 1H), 4.01 (t, J = 6.6 Hz, 2H), 4.11–4.58
(m, 5H), 4.77 (s, 2H), 5.37–5.44 (m, 1H), 5.50–5.59 (m, 1H),
6.95–7.00 (m, 2H), 7.48–7.64 (m, 4H), 8.04–8.09 (m, 2H).
13C NMR (67.8 MHz, CDCl3): d 14.0, 14.1, 22.6, 24.8, 25.7,
27.4, 29.0, 29.1, 29.2, 29.3, 29.5, 31.6, 31.8, 34.1, 35.4, 36.8,
55.6, 63.4, 63.9, 71.5, 72.7, 77.2, 96.0, 114.9, 125.2, 126.3,
126.5, 127.7, 128.0, 128.3, 130.2, 132.0, 133.3, 145.6, 159.5,
166.2, 173.5. IR (neat): 2929, 2857, 1721, 1605, 1497, 1466,
20
26
1172, 1111, 1070, 1031, 921, 712, 447, 418 cmꢀ1. ½aꢁD ¼ þ14:6
1274, 1186, 1111, 1035, 829, 757 cmꢀ1. ½aꢁD ¼ þ0:9 (c 0.29,
(c 0.091, CHCl3).
CHCl3).